JINGHAO MEDICAL
872925
TONGYI AEROSPACE
871642
ESKONJAC
839273
4
Jiangsu Olive Sensors High-Tech
300507
5
Jing-Jin Electric Technologies
688280
(FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (Q2)Jun 30, 2020 | (Q1)Mar 31, 2020 | (FY)Dec 31, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -45.76%22.88M | 444.95%42.17M | -83.34%7.74M | 431.46%46.46M | -66.50%8.74M | -141.07%-1.12M | 346.48%26.09M | 2.72M | ||
Net income from continuing operations | -14.94%25.97M | 15.46%30.53M | -25.21%26.44M | -27.79%35.35M | 85.43%48.96M | ---- | -31.28%2.84M | 102.38%26.4M | ---- | --4.13M |
Operating gains losses | ---- | -238.71%-86K | 107.43%62K | 95.76%-835K | ---19.71M | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 1.14%3.82M | 13.21%3.78M | 32.67%3.34M | -25.05%2.52M | 218.80%3.36M | ---- | 353.39%535K | 254.55%1.05M | ---- | --118K |
Deferred tax | -152.38%-33K | 218.87%63K | -107.43%-53K | 493.92%713K | -195.26%-181K | ---- | -142.44%-73K | -21.16%190K | ---- | --172K |
Other non cash items | -918.75%-131K | -78.95%16K | -26.92%76K | 11.83%104K | --93K | ---- | ---- | ---- | ---- | ---- |
Change In working capital | -249.68%-8.48M | 123.87%5.66M | -373.08%-23.73M | 129.16%8.69M | -1,610.51%-29.8M | ---- | -193.44%-4.88M | 93.19%-1.74M | ---- | ---1.66M |
-Change in receivables | -87.35%1.92M | 136.11%15.21M | -311.54%-42.11M | 182.79%19.9M | -89.24%-24.04M | ---- | 17.16%-5.25M | 59.53%-12.71M | ---- | ---6.34M |
-Change in prepaid assets | 97.69%-514K | -231.99%-22.27M | 257.96%16.87M | 44.77%-10.68M | -525.15%-19.34M | ---- | -101.25%-49K | -16.99%4.55M | ---- | --3.91M |
-Change in payables and accrued expense | -178.42%-9.75M | 432.42%12.43M | 388.49%2.34M | -96.47%478K | 166.33%13.56M | ---- | -5.66%417K | 1.17%5.09M | ---- | --442K |
-Change in other current assets | -102.35%-16K | 301.18%682K | 131.66%170K | -221.49%-537K | -64.95%442K | ---- | -48.50%291K | 132.00%1.26M | ---- | --565K |
-Change in other current liabilities | 94.07%-22K | 42.12%-371K | -64.78%-641K | -3.46%-389K | -21.29%-376K | ---- | 6.77%-179K | -1,048.15%-310K | ---- | ---192K |
-Change in other working capital | -621.43%-101K | 96.07%-14K | -309.20%-356K | -123.08%-87K | -110.48%-39K | ---- | -141.86%-104K | 150.96%372K | ---- | ---43K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -45.76%22.88M | 444.95%42.17M | -83.34%7.74M | 431.46%46.46M | -66.50%8.74M | -93.94%112K | -141.07%-1.12M | 346.48%26.09M | --1.85M | --2.72M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -828,633.33%-24.86M | 99.96%-3K | -660.13%-7.99M | 76.21%-1.05M | 71.16%-4.42M | 0 | -9,911.76%-15.32M | -2.35M | ||
Net PPE purchase and sale | 66.67%-1K | 88.00%-3K | 65.28%-25K | -22.03%-72K | -742.86%-59K | ---- | --0 | 95.42%-7K | ---- | ---4K |
Net intangibles purchase and sale | ---24.86M | --0 | -193.01%-7.96M | 0.15%-2.72M | 82.22%-2.72M | ---- | --0 | ---15.31M | ---- | ---2.35M |
Net business purchase and sale | ---- | ---- | ---- | ---12K | --0 | ---- | ---- | --0 | ---- | ---- |
Net investment purchase and sale | ---- | ---- | ---- | 206.96%1.75M | ---1.64M | ---- | ---- | --0 | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -828,633.33%-24.86M | 99.96%-3K | -660.13%-7.99M | 76.21%-1.05M | 71.16%-4.42M | -5,947.06%-994K | --0 | -9,911.76%-15.32M | --17K | ---2.35M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -87.14%10.55M | 16,045.87%82.02M | -96.18%508K | 146.91%13.29M | 186.46%5.38M | 384.16%4.32M | -180.90%-6.22M | -1.52M | ||
Net issuance payments of debt | 93.66%5.56M | 2,039.19%2.87M | 91.31%-148K | -130.96%-1.7M | 158.50%5.5M | ---- | 336.47%4.3M | -190.81%-9.41M | ---- | ---1.82M |
Net common stock issuance | --0 | --80M | --0 | --15.29M | --0 | ---- | ---- | --0 | ---- | ---- |
Net other financing activities | 688.10%4.99M | -229.42%-849K | 318.67%656K | -143.90%-300K | -103.86%-123K | ---- | -92.26%23K | 127.14%3.19M | ---- | --297K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -87.14%10.55M | 16,045.87%82.02M | -96.18%508K | 146.91%13.29M | 186.46%5.38M | --0 | 384.16%4.32M | -180.90%-6.22M | ---1.87M | ---1.52M |
Net cash flow | ||||||||||
Beginning cash position | 175.99%194.53M | -8.82%70.48M | 335.97%77.3M | 156.27%17.73M | 183.91%6.92M | 645.03%9.96M | 183.91%6.92M | -56.83%2.44M | --1.34M | --2.44M |
Current changes in cash | -93.10%8.56M | 48,036.43%124.19M | -99.56%258K | 504.80%58.69M | 113.27%9.7M | -44,000.00%-882K | 379.09%3.2M | 249.38%4.55M | ---2K | ---1.15M |
Effect of exchange rate changes | -3,543.62%-5.43M | 97.89%-149K | -903.41%-7.08M | -20.49%881K | 1,729.41%1.11M | 47.73%-23K | -437.50%-162K | 58.02%-68K | ---44K | --48K |
End cash Position | 1.61%197.66M | 175.99%194.53M | -8.82%70.48M | 335.97%77.3M | 156.27%17.73M | 601.47%9.06M | 645.03%9.96M | 183.91%6.92M | --1.29M | --1.34M |
Free cash flow | -104.71%-1.99M | 16,968.40%42.17M | -100.57%-250K | 632.63%43.67M | -44.68%5.96M | -93.94%112K | -399.73%-1.12M | 200.33%10.77M | --1.85M | --373K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- |